Veralto VLTO
- Market cap
- $25.4B
- PE
- 26.3×
- 2y median 28.1×
- Forward PE
- 23.1×
- 3y median 26.4×
- Price to sales
- 4.5×
- EV/EBIT
- 20.5×
- Revenue, 12 months
- $5.7B
- +6% on a year ago
- Net margin
- 17.3%
- Free cash flow yield
- 4.1%
Veralto trades at 26.3× trailing earnings, cheaper than 69% of the last ten years. Revenue was $5.7B over the last twelve months, up 6% on a year earlier with a 17% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.3B+3% | $1.3B+3% | $1.2B+2% | $1.3B+3% | $1.3B+5% | $1.3B+4% | $1.3B+7% | $1.4B+6% | $1.4B+7% | $1.4B+4% | $1.4B+7% | $1.5B+8% | |
| Cost of revenue | $532M+1% | $542M+1% | $499M−4% | $514M−3% | $531M−0% | $544M+0% | $527M+6% | $549M+7% | $560M+6% | $568M+4% | $568M+8% | $572M+4% |
| Gross profit | $723M+4% | $746M+5% | $747M+6% | $774M+7% | $783M+8% | $801M+7% | $805M+8% | $822M+6% | $844M+8% | $828M+3% | $854M+6% | $902M+10% |
| R&D | $55M+6% | $57M+8% | $60M+7% | $61M+7% | $63M+15% | $69M+21% | $64M+7% | $67M+10% | $67M+6% | $68M−1% | $68M+6% | $73M+9% |
| SG&A | $395M+11% | $403M+11% | $394M+9% | $414M+10% | $412M+4% | $424M+5% | $419M+6% | $442M+7% | $451M+10% | $444M+5% | $448M+7% | $514M+16% |
| $273M−4% | $286M−3% | $293M+0% | $299M+4% | $308M+13% | $308M+8% | $322M+10% | $313M+5% | $326M+6% | $316M+3% | $338M+5% | $315M+1% | |
| Interest expense | $5M | $25M | $28M | $30M | $27M+440% | $28M+12% | $27M−4% | $28M−7% | $21M−22% | $20M−29% | $24M−11% | $27M−4% |
| Pre-tax income | $268M−6% | $261M−12% | $250M−14% | $270M−2% | $286M+7% | $280M+7% | $289M+16% | $285M+6% | $306M+7% | $293M+5% | $321M+11% | $289M+1% |
| $63M−6% | $61M−23% | $66M−2% | $67M+2% | $67M+6% | $53M−13% | $64M−3% | $63M−6% | $67M+0% | $39M−26% | $67M+5% | $48M−24% | |
| Net income | $205M−6% | $200M−7% | $184M−18% | $203M−3% | $219M+7% | $227M+14% | $225M+22% | $222M+9% | $239M+9% | $254M+12% | $254M+13% | $241M+9% |
| $0.83−7% | $0.81−8% | $0.74−19% | $0.81−5% | $0.88+6% | $0.91+12% | $0.90+22% | $0.89+10% | $0.95+8% | $1.01+11% | $1.02+13% | $0.98+10% | |
| 246.3M+0% | 247.1M+0% | 248.8M+1% | 249.3M+1% | 250M+2% | 250.2M+1% | 250.1M+1% | 249.9M+0% | 250.6M+0% | 250.6M+0% | 249.2M−0% | 245.8M−2% |
EPS, diluted: 4 periods, Q4 FY22 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 3 periods, Q4 FY22 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY23: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q3 FY26 | $1.5B | $1.5B to $1.5B | $1.09 | $1.08 to $1.10 | 8 |
| Q4 FY26 | $1.5B | $1.5B to $1.5B | $1.13 | $1.12 to $1.15 | 8 |
| Q1 FY27 | $1.5B | $1.5B to $1.5B | $1.15 | $1.14 to $1.17 | 3 |
| Q2 FY27 | $1.6B | $1.5B to $1.6B | $1.15 | $1.14 to $1.16 | 5 |
| Q3 FY27 | $1.6B | $1.6B to $1.6B | $1.22 | $1.20 to $1.23 | 3 |
| Q4 FY27 | $1.6B | $1.6B to $1.6B | $1.28 | $1.26 to $1.29 | 6 |
| Q1 FY28 | $1.6B | $1.6B to $1.6B | $1.29 | $1.28 to $1.31 | 4 |
| Q2 FY28 | $1.6B | $1.6B to $1.7B | $1.32 | $1.31 to $1.34 | 6 |
Peers
Companies in Industrials nearest Veralto's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| VLTOVeralto | $25.4B | 26.3× | 28.1× | 23.1× | 4.5× | +6% | 17.3% |
| XYLXylem | $25.4B | 25.9× | 37.5× | 18.6× | 2.8× | +5% | 11.2% |
| EXPDExpeditors International of Washington | $25.5B | 28.6× | 22.6× | 24.7× | 2.1× | +7% | 7.6% |
| DOVDover | $26.8B | 24.0× | 19.2× | 17.7× | 3.2× | +8% | 13.5% |
| CPRTCopart | $26.9B | 18.7× | 31.8× | 17.9× | 5.8× | +0% | 31.8% |
| SYMSymbotic | $23.8B | 436× | 467× | 110× | 9.0× | +21% | 0.5% |
| HUBBHubbell | $23.7B | 26.5× | 25.2× | 20.6× | 3.8× | +11% | 14.5% |
| IRIngersoll Rand | $28.5B | 30.2× | 39.8× | 19.6× | 3.6× | +8% | 12.1% |
| EMEEMCOR | $28.6B | 20.1× | 20.3× | 18.6× | 1.5× | +19% | 7.7% |
| OTISOtis Worldwide | $28.6B | 19.3× | 26.4× | 17.5× | 1.9× | +5% | 10.2% |
| XPOXPO Logistics | $21.5B | 53.9× | 27.4× | 30.4× | 2.5× | +7% | 4.7% |
| Peer median | $26.2B | 26.2× | 26.9× | 19.1× | 3.0× | +7% | 10.7% |
More on Veralto
Each number over time
- PE ratio
- Forward PE
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Dividend yield
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Industrial - Pollution & Treatment Controls
- Sector
- Industrials
Valuation data, not investment advice. Prices as of .